About 8 Trademarks found that are owned by ZelIra Therapeutics Limited

Non-medicated skin care preparations containing cannabinoids solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis

Preparations for medical purposes derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder; none of the foregoing being preparations to treat deficiencies of Alpha-One proteinase inhibitors; none of the goods being for the treatment and detection of cervical cancer and related infections

Conducting clinical trials for others; research relating to science; provision of pharmaceutical research services; project management and planning of clinical trials, namely, consulting services for others in the field of design, planning, and implementation project management of clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; scientific research relating to medicinal use of cannabis; scientific research and development of medicinal cannabis products; medical research; scientific research for medical purposes; scientific research; none of the foregoing in relation to the treatment of deficiencies of Alpha-One proteinase inhibitors; none of the services being for the treatment and detection of cervical cancer and related infections

Preparations for medical purposes derived from cannabis for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, Alzheimer's, depression, autism and post-traumatic stress disorder; all of the foregoing containing or solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD

Color is not claimed as a feature of the mark.

The mark consists of a stylized letter "Z" inside of a circle.

The mark consists of a stylized letter "Z" inside of a circle.

Non-prescription medicines, namely, pills, tablets, capsules, caplets, and pharmaceutical preparations for the treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological, immune system related diseases and disorders, Parkinson's disease, insomnia, diabetic neuropathy, Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome; medical and pharmaceutical preparations for the treatment and prevention of viral, bacterial, fungal, parasitic metabolic, endocrine, hepatological, respiratory, nervous system, neurological, gastrointestinal, digestive, inflammatory, pulmonary, hormonal, dermatological, psychiatric, addictive, behavioral, infectious, addictive, musculoskeletal, cardiovascular, ophthalmic, cardiopulmonary, genitourinary, sexual dysfunction, oncological, immune system related diseases and disorders, Parkinson's disease, insomnia, diabetic neuropathy, Influenza, Coronaviruses, pancreatic deficiencies, gastrointestinal disease, internal malabsorption syndromes, Autism, Autism Spectrum Disorder, Attention Deficit Hyperactivity Disorder and Williams Syndrome

Medical cannabis and derivatives thereof; medical and pharmaceutical preparations, including for use in treating insomnia

Topical preparations; Topical preparations that target symptoms associated with Peripheral Artery Disease (PAD) and Diabetic Neuropathies containing cannabinoids solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis; Topical preparations for treatment of pain associated with Peripheral Artery Disease (PAD) and Diabetic Neuropathies containing cannabinoids solely derived from hemp with a delta-9 tetrahydrocannabinol concentration of not more than 0.3 percent on a dry weight basis

Medical cannabis and derivatives thereof; preparations for medical purposes derived from cannabis; therapeutic agents (medical); therapeutic creams (medical); therapeutic drugs (medical); natural healthcare preparations (medicaments); natural oils (medicinal); natural pharmaceutical products; pharmaceutical products derived from natural sources; pharmaceutical preparations; pharmaceutical preparations for human use; medical preparations; pharmaceutical preparations for health care; pharmaceutical preparations for nasal use; pharmaceutical preparations for oral use; pharmaceutical preparations for topical use; pharmaceutical preparations and substances for the prevention, management and treatment of opioid addiction, cancer including breast cancer, brain cancer and pancreatic cancer, pain, chronic pain, terminal illnesses, epilepsy, arthritis, crohn's disease, insomnia, diabetes, eczema, psychiatric diseases and disorders including mood disorders, anxiety disorders, sleep disorders, cognitive disorders, alzheimer's, depression, autism and post-traumatic stress disorder; pain killers (pharmaceuticals); pharmaceutical preparations in the form of foams, gels, emulsions, elixirs, lotions, ointments, tinctures, creams, liquids, oils, lozenges, tablets, capsules, sprays and skin patches; analgesic preparations; antibacterial preparations; medical products; medicinal plants and herbs; medicinal oils; herbal preparations for medical purposes; plant extracts for medical use; plant extracts for pharmaceutical use; preparations for medical purposes

Clinical trials; project management and planning of clinical trials; conducting clinical trials; research relating to pharmaceuticals; research relating to medicinal use of marijuana and cannabis; research and development of medicinal marijuana and cannabis products; medical research; medical research (scientific research for medical purposes); scientific research; research relating to science; provision of medical research services